Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Renhe Pharma Plans $140 Million Fund Raise for M&A

publication date: Mar 2, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Renhe Pharmacy has plans for a 50 million share private placement, priced at 18.36 RMB per share, which will bring in 918 million RMB ($139.7 million). Renhe, which makes and distributes OTC drugs, will use the money to buy stakes in four companies. More details....

Stock Symbol: (SHE: 000650)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners